House passes spending bill that includes funding for the Children's Health Insurance Program for 6 years; researchers work on an experimental blood test that could detect 8 cancers; President Donald Trump plans to slash the budget of the Office of National Drug Control Policy by as much as 95%.
By a vote of 230 to 197, the House of Representatives passed a spending bill that would a government shutdown. According to The New York Times, the bill provides funding for the Children’s Health Insurance Program (CHIP) for 6 years. However, Senate Republicans are unlikely to sway enough Democratic votes. Democrats want more concessions as part of the spending bill, including a stronger government response to the opioid epidemic and protection for young immigrants brought to the country illegally when they were children.
A blood test in development might be able to detect 8 common cancers in the earliest stages, when those cancers are treatable. Researchers hope that the experimental test—which focuses on breast, colon, esophagus, liver, lung, ovarian, pancreas, and stomach cancers—will only cost $500, reported NPR. The researchers reported that, while the test was only successful 40% of the time in patients with stage 1 cancers, the finding still represents an important milestone in detecting cancers.
The budget of the Office of National Drug Control Policy could be cut by as much as 95%, according to plans from President Donald Trump. The office is responsible for coordinating the government’s response to the opioid crisis, according to Politico. The reduction in funding would mean moving the office’s 2 main grant programs to HHS and the Justice Department. The administration tried to eliminate those grant programs earlier, but received pushback from both parties.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Similar In-Hospital, Long-Term Survival Rates Found Among Male, Female Patients With AECOPD
March 18th 2024This study analyzed sex differences among patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), with findings indicating that female smokers experience worse hospital outcomes despite similar overall survival rates.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
AstraZeneca joins efforts to address high drug prices by capping out-of-pocket costs for its inhalers; Opill, the first OTC birth control pill, is now accessible through online sales; expansion prompts questions on the effectiveness and regulation of remote monitoring technology.
Read More